Solar urticaria – An Australian case series of 83 patients. (25th December 2018)

• Record Type: Journal Article
• Authors: Photiou, Louise; Foley, Peter; Ross, Gayle
• Is Part Of: Australasian journal of dermatology. Volume 60:Number 2(2019)
• Page Start: 110
• Page End: 117
• Publication Date: 2018-12-25
• Subjects: omalizumab -- photodermatosis -- phototesting -- solar urticaria -- urticaria; Dermatology -- Periodicals; Dermatology -- Australasia -- Periodicals; 616.5005
• DOI: 10.1111/ajd.12975
• Languages: English
• ISSNs: 0004-8380

Abstract

Abstract: Solar urticaria (SU) is a rare form of urticaria with a pathogenesis that is poorly understood. It affects all skin types, can be difficult to diagnose, and is challenging to manage effectively. We conducted a retrospective review of patients with SU in our institution. A total of 83 patients (56 females) were identified as having SU. The mean age was 32 years (7–74) at first development of symptoms/signs of SU. Pruritus was the most common symptom reported (79%). Of the 60 patients who underwent monochromator testing at least once, 35 had SU confirmed with most reacting to visible light and UVA, or to UVA alone. Antihistamines and sun avoidance remain the mainstay treatment for SU but other treatments, including omalizumab, are of potential interest in treating patients with recalcitrant SU. The characterisation of this large case series of patients may help dermatologists recognise and manage this rare disorder appropriately.